Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
Kersten MJ, Amaador K, Minnema MC, Vos JMI, Nasserinejad K, Kap M, Kastritis E, Gavriatopoulou M, Kraan W, Chamuleau MED, Deeren D, Tick LW, Doorduijn JK, Offner F, Böhmer LH, Liu RD, Pals ST, Dimopoulos MA. Kersten MJ, et al. Among authors: dimopoulos ma. J Clin Oncol. 2022 Jan 1;40(1):40-51. doi: 10.1200/JCO.21.00105. Epub 2021 Aug 13. J Clin Oncol. 2022. PMID: 34388022 Free PMC article. Clinical Trial.
Emerging drugs for Waldenström's macroglobulinemia.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Expert Opin Emerg Drugs. 2011 Mar;16(1):45-57. doi: 10.1517/14728214.2011.523418. Expert Opin Emerg Drugs. 2011. PMID: 21352069 Review.
Proteasome Inhibitors in Waldenström Macroglobulinemia.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Hematol Oncol Clin North Am. 2018 Oct;32(5):829-840. doi: 10.1016/j.hoc.2018.05.011. Epub 2018 Jul 25. Hematol Oncol Clin North Am. 2018. PMID: 30190021 Review.
Angiogenesis in Waldenström's macroglobulinemia.
Terpos E, Tasidou A, Kastritis E, Eleftherakis-Papaiakovou E, Gavriatopoulou M, Migkou M, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma. 2009 Mar;9(1):46-9. doi: 10.3816/CLM.2009.n.011. Clin Lymphoma Myeloma. 2009. PMID: 19362971 Review.
Management of relapsed and relapsed refractory myeloma.
Kastritis E, Mitsiades CS, Dimopoulos MA, Richardson PG. Kastritis E, et al. Among authors: dimopoulos ma. Hematol Oncol Clin North Am. 2007 Dec;21(6):1175-215, x. doi: 10.1016/j.hoc.2007.08.014. Hematol Oncol Clin North Am. 2007. PMID: 17996594 Review.
Thalidomide in the treatment of multiple myeloma.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Best Pract Res Clin Haematol. 2007 Dec;20(4):681-99. doi: 10.1016/j.beha.2007.09.001. Best Pract Res Clin Haematol. 2007. PMID: 18070713 Review.
1,275 results